Immunohistochemical results showed that the expression levels of SPP1 and CXCL9 were significantly upregulated in NASH liver tissues compared to healthy liver tissues, which is consistent with the results of the bioinformatics analysis mentioned previously (Figure 3D). The gene discussed is SPP1; the disease is metabolic dysfunction-associated steatohepatitis.